Differential enhancement of leukaemia cell differentiation without elevation of intracellular calcium by plant-derived sesquiterpene lactone compounds

British Journal of Pharmacology

Volumn 155, Issue 6, 2008, Pages 814-825

  Kim, S H ^a   Danilenko, M ^b   Kim, T S ^a  

^a Korea University   (South Korea)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

All trans retinoic acid; Differentiation; Intracellular calcium; Leukaemia; NF B; Sesquiterpene lactones

Indexed keywords

CALCIUM; COSTUNOLIDE; FLUORESCENT DYE; HELENALIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PARTHENOLIDE; PHOSPHOTRANSFERASE; PROTEIN KINASE C; RETINOIC ACID; SCLAREOLIDE; SESQUITERPENE LACTONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOFLUOROMETRY; DRUG DNA BINDING; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME ACTIVITY; GEL MOBILITY SHIFT ASSAY; GIEMSA STAIN; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKEMIA CELL; PLANT; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; WESTERN BLOTTING;

CALCIUM; CALCIUM SIGNALING; CELL DIFFERENTIATION; HL-60 CELLS; HUMANS; LACTONES; LEUKEMIA; PLANT EXTRACTS; SESQUITERPENES; SIGNAL TRANSDUCTION; TRETINOIN;

EID: 57349129039     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.319     Document Type: Article

References (47)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR (1995). PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270: 27489-27494.
2. Barnea E, Levy R, Zimlichman R, Shany S (1990). 1,25-Dihydroxy-vitamin D3 enhances cytosolic free calcium in HL-60 cells. Exp Hematol 18: 1147-1151.
3. Beere HM, Hickman JA (1993). Differentiation: a suitable strategy for cancer chemotherapy? Anticancer Drug Des 8: 299-322.
4. Bennett MT, Sirrs S, Yeung JK, Smith CA (2005). Hypercalcemia due to all trans retinoic acid in the treatment of acute promyelocytic leukemia potentiated by voriconazole. Leuk Lymphoma 46: 1829-1831.
5. Bertagnolo V, Neri LM, Marchisio M, Mischiati C, Capitani S (1999). Phosphoinositide 3-kinase activity is essential for all-trans-retinoic acid-induced granulocytic differentiation of HL-60 cells. Cancer Res 59: 542-546.
6. Breitman TR, He RY (1990). Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60. Cancer Res 50: 6268-6273.
7. Breitman TR, Selonick SE, Collins SJ (1980). Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 77: 2936-2940.
8. Castro V, Murillo R, Klaas CA, Meunier C, Mora G, Pahl HL et al. (2000). Inhibition of the transcription factor NF-κB by sesquiterpene lactones from Podachaenium eminens. Planta Med 66: 591-595.
9. Coligan JE, Kruisbeck AM, Margulies DH, Shevach EM, Strober W (1995). Current protocols in immunology. Wiley-Liss: New York.
10. Collins SJ, Ruscetti FW, Gallagher RE, Gallo RC (1979). Normal functional characteristics of cultured human promyelocytic leukemia cells (HL-60) after induction of differentiation by dimethylsulfoxide. J Exp Med 149: 969-974.
11. 3 in leukemia cells, but does not promote elevation of basal levels of intracellular calcium. Cancer Res 63: 1325-1332.
12. Danilenko M, Wang X, Studzinski GP (2001). Carnosic acid and promotion of monocytic differentiation of HL60-G cells initiated by other agents. J Natl Cancer Inst 93: 1224-1233.
13. el-Feraly FS, Chan YM (1978). Isolation and characterization of the sesquiterpene lactones costunolide, parthenolide, costunolide diepoxide, santamarine, and reynosin from Magnolia grandiflora L. J Pharm Sci 67: 347-350.
14. Hehner SP, Hofmann TG, Droge W, Schmitz ML (1999). The antiinflammatory sesquiterpene lactone parthenolide inhibits NF-κB by targeting the IκB kinase complex. J Immunol 163: 5617-5623.
15. Hu X, Moscinski LC, Valkov NI, Fisher AB, Hill BJ, Zuckerman KS (2000). Prolonged activation of the mitogen-activated protein kinase pathway is required for macrophage-like differentiation of a human myeloid leukemic cell line. Cell Growth Differ 11: 191-200.
16. Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L et al. (1988). Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567-572.
17. Hughes PJ, Zhao Y, Chandraratna RA, Brown G (2006). Retinoid-mediated stimulation of steroid sulfatase activity in myeloid leukemic cell lines requires RARalpha and RXR and involves the phosphoinositide 3-kinase and ERK-MAP kinase pathways. J Cell Biochem 97: 327-350.
18. 3-induced differentiation of human leukaemia HL-60 cells into monocytes by parthenolide via inhibition of NF-κB activity. Br J Pharmacol 135: 1235-1244.
19. Kansas GS, Muirhead MJ, Dailey MO (1990). Expression of the CD11/ CD18, leukocyte adhesion molecule 1, and CD44 adhesion molecules during normal myeloid and erythroid differentiation in humans. Blood 76: 2483-2492.
20. 3-induced differentiation of human promyelocytic leukemia cells into monocytes by costunolide, a germacranolide sesquiterpene lactone. Biochem Pharmacol 64: 1233-1242.
21. Kim SH, Oh SM, Kim TS (2005). Induction of human leukemia HL-60 cell differentiation via a PKC/ERK pathway by helenalin, a pseudoguainolide sesquiterpene lactone. Eur J Pharmacol 511: 89-97.
22. Kim SH, Song JH, Choi BG, Kim HJ, Kim TS (2006). Chemical modification of santonin into a diacetoxy acetal form confers the ability to induce differentiation of human promyelocytic leukemia cells via the down-regulation of NF-κB DNA binding activity. J Biol Chem 281: 13117-13125.
23. Komada F, Nishikawa M, Uemura Y, Morita K, Hidaka H, Shirakawa S (1991). Expression of three major protein kinase C isozymes in various types of human leukemic cells. Cancer Res 51: 4271-4278.
24. Kopp E, Ghosh S (1994). Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956-959.
25. Lemez P (1995). Hypercalcaemia caused by all-trans retinoic acid (ATRA) treatment in a case of acute promyelocytic leukaemia was manageable after decreasing the ATRA dose to 27mg/m2/day. Eur J Haematol 55: 275-276.
26. Lengfelder E, Saussele S, Weisser A, Buchner T, Hehlmann R (2005). Treatment concepts of acute promyelocytic leukemia. Crit Rev Oncol Hematol 56: 261-274.
27. 3 induced activation and subsequent nuclear translocation of MAPK is upstream regulated by PKC in HL-60 cells. Biochem Biophys Res Commun 241: 419-426.
28. Mathieu J, Besançon F (2006). Arsenic trioxide represses NF-kappaB activation and increases apoptosis in ATRA-treated APL cells. Ann NY Acad Sci 1090: 203-208.
29. Miranda MB, McGuire TF, Johnson DE (2002). Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia 16: 683-692.
30. Mori H, Kawamori T, Tanaka T, Ohnishi M, Yamahara J (1994). Chemopreventive effect of costunolide, a constituent of oriental medicine, on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Lett 83: 171-175.
31. Pan Q, Granger J, O'Connell TD, Somerman MJ, Simpson RU (1997). Promotion of HL-60 cell differentiation by 1,25-dihydroxyvitamin D3 regulation of protein kinase C levels and activity. Biochem Pharmacol 54: 909-915.
32. Ross JJ, Arnason JT, Birnboim HC (1999). Low concentrations of the feverfew component parthenolide inhibit in vitro growth of tumor lines in a cytostatic fashion. Planta Med 65: 126-129.
33. Savickiene J, Treigyte G, Borutinskaite V, Navakauskiene R, Magnusson KE (2006). The histone deacetylase inhibitor FK228 distinctly sensitizes the human leukemia cells to retinoic acid-induced differentiation. Ann NY Acad Sci 1091: 368-384.
34. Schmidt TJ (1997). Helenanolide-type sesquiterpene lactones-III. Rates and stereochemistry in the reaction of helenalin and related helenanolides with sulfhydryl containing biomolecules. Bioorg Med Chem 5: 645-653.
35. Sharma HW, Narayanan R (1996). The NF-kappaB transcription factor in oncogenesis. Anticancer Res 16: 589-596.
36. 3: possible relationship to NF-κB. Leukemia 11: 1546-1553.
37. 3. Cancer Lett 125: 157-164.
38. Sokoloski JA, Sartorelli AC, Rosen CA, Narayanan R (1993). Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood 82: 625-632.
39. 3 and retinoic acid. Nutr Cancer 41: 135-144.
40. 3 induces differentiation of human promyelocytic leukemia cells (HL-60) into monocyte-macrophages, but not into granulocytes. Biochem Biophys Res Commun 117: 86-92.
41. van der Schoot CE, von dem Borne AE, Tetteroo PA (1987). Characterization of myeloid leukemia by monoclonal antibodies, with an emphasis on antibodies against myeloperoxidase. Acta Haematol 78: 32-40.
42. 3 in induction of leukemia HL60 cell differentiation through the JNK/AP-1/Egr-1 pathway. J Cell Physiol 204: 964-974.
43. 3. J Cell Biochem 89: 1087-1101.
44. Wang X, Gardner JP, Kheir A, Uskokovic MR, Studzinski GP (1997). Synergistic induction of HL60 cell differentiation by ketoconazole and 1-desoxy analogues of vitamin D3. J Natl Cancer Inst 89: 1199-1206.
45. Wu XZ, Shao GY, Chen S, Wang XW, Wang ZY (1989). Studies on the relationship between protein kinase C and differentiation of human promyelocytic leukemia cells induced by retinoic acid. Leuk Res 13: 869-874.
46. Yen A, Roberson MS, Varvayanis S (1999). Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation. In vitro Cell Dev Biol Anim 35: 527-532.
47. Yen A, Roberson MS, Varvayanis S, Lee AT (1998). Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 58: 3163-3172.